Clinical Report: Kfir Ben-David, M.D., FACS, Joins Lynn Cancer Institute

Overview

Kfir Ben-David, M.D., FACS, has joined the Eugene M. and Christine E. Lynn Cancer Institute, specializing in complex minimally invasive gastrointestinal surgery and surgical oncology. His expertise includes esophageal, gastric, and pancreatic cancers, with a focus on advanced robotic techniques.

Background

The recruitment of specialized surgical oncologists like Dr. Ben-David is important for the field of surgical oncology. His experience in minimally invasive techniques is relevant to current practices in the specialty.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

• Dr. Ben-David specializes in complex minimally invasive gastrointestinal surgery.
• He has extensive experience in robotic esophagectomy and robotic Whipple procedures.
• Dr. Ben-David has authored over 100 peer-reviewed publications and book chapters.
• He emphasizes a patient-centered approach, prioritizing compassion and shared decision-making.
• He is fluent in English and Hebrew and medically conversant in Spanish.

Clinical Implications

Dr. Ben-David's addition to the surgical team is a notable development for the Lynn Cancer Institute.

Conclusion

Dr. Ben-David's expertise in surgical oncology and minimally invasive techniques will contribute significantly to the multidisciplinary cancer care team at the Lynn Cancer Institute.

Related Resources & Content

1. baptist health south florida, Eugene M. & Christine E. Lynn Cancer Institute, 2023 -- Kfir Ben-David, M.D., FACS, Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Surgical Oncologist
2. baptist health south florida — Aurelio B. Castrellon, M.D., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist
3. baptist health south florida — Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist
4. The ASCO Post — Benjamin Levy, MD, to Lead Medical Oncology at Sibley Memorial
5. baptist health south florida — Eugene M. & Christine E. Lynn Cancer Institute Treats First Patient with Tarlatamab, Expanding Advanced Therapeutic Options for Patients with Refractory Malignancies
6. ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma - PMC
7. Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial - PMC
8. https://www.oregon.gov/oha/HPA/DSI-HERC/MembersOnly/7.1d%20NCCN%202.2025%20pancreatic.pdf
9. Robotic versus Open Pancreatoduodenectomy (PORTAL): multicentre, single masked, phase 3, non-inferiority randomised controlled trial - PubMed